These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15507197)

  • 1. The prediction of adverse maternal outcomes in preeclampsia.
    von Dadelszen P; Magee LA; Devarakonda RM; Hamilton T; Ainsworth LM; Yin R; Norena M; Walley KR; Gruslin A; Moutquin JM; Lee SK; Russell JA
    J Obstet Gynaecol Can; 2004 Oct; 26(10):871-9. PubMed ID: 15507197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Instituting surveillance guidelines and adverse outcomes in preeclampsia.
    Menzies J; Magee LA; Li J; MacNab YC; Yin R; Stuart H; Baraty B; Lam E; Hamilton T; Lee SK; von Dadelszen P;
    Obstet Gynecol; 2007 Jul; 110(1):121-7. PubMed ID: 17601906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of platelet counts in the assessment of inpatient women with preeclampsia.
    Laskin S; Payne B; Hutcheon JA; Qu Z; Douglas MJ; Ford J; Lee T; Magee LA; von Dadelszen P
    J Obstet Gynaecol Can; 2011 Sep; 33(9):900-8. PubMed ID: 21923987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
    Leaños-Miranda A; Navarro-Romero CS; Sillas-Pardo LJ; Ramírez-Valenzuela KL; Isordia-Salas I; Jiménez-Trejo LM
    Hypertension; 2019 Oct; 74(4):991-997. PubMed ID: 31446801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new predicting model of preeclampsia based on peripheral blood test value.
    Han Q; Zheng W; Guo XD; Zhang D; Liu HF; Yu L; Yan JY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7222-7229. PubMed ID: 32706060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
    von Dadelszen P; Payne B; Li J; Ansermino JM; Broughton Pipkin F; Côté AM; Douglas MJ; Gruslin A; Hutcheon JA; Joseph KS; Kyle PM; Lee T; Loughna P; Menzies JM; Merialdi M; Millman AL; Moore MP; Moutquin JM; Ouellet AB; Smith GN; Walker JJ; Walley KR; Walters BN; Widmer M; Lee SK; Russell JA; Magee LA;
    Lancet; 2011 Jan; 377(9761):219-27. PubMed ID: 21185591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia?
    Tokmak A; Güney G; Aksoy RT; Guzel AI; Topcu HO; Keçecioğlu TS; Uygur D
    J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1451-6. PubMed ID: 25133554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia.
    Kozic JR; Benton SJ; Hutcheon JA; Payne BA; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Oct; 33(10):995-1004. PubMed ID: 22014776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIERS proteinuria: relationship with adverse maternal and perinatal outcome.
    Payne B; Magee LA; Côté AM; Hutcheon JA; Li J; Kyle PM; Menzies JM; Peter Moore M; Parker C; Pullar B; von Dadelszen P; Walters BN; ; von Dadelszen P; Magee LA; Douglas MJ; Walley KR; Russell JA; Lee SK; Gruslin A; Smith GN; Côté AM; Moutquin JM; Brown MA; Davis G; Walters BN; Sass N; Duan T; Zhou J; Mahajan S; Noovao A; McCowan LA; Kyle P; Moore MP; Bhutta SZ; Bhutta ZA; Hall ; Steyn DW; Broughton Pipkin F; Loughna P; Robson S; de Swiet M; Walker JJ; Grobman WA; Lindheimer MD; Roberts JM; Mark Ansermino J; Benton S; Cundiff G; Hugo D; Joseph KS; Lalji S; Li J; Lott P; Ouellet AB; Shaw D; Keith Still D; Tawagi G; Wagner B; Biryabarema C; Mirembe F; Nakimuli A; Tsigas E; Merialdi M; Widmer M
    J Obstet Gynaecol Can; 2011 Jun; 33(6):588-597. PubMed ID: 21846448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.
    Elia EG; Robb AO; Hemming K; Price MJ; Riley RD; French-Constant A; Denison FC; Kilby MD; Morris RK; Stock SJ
    Acta Obstet Gynecol Scand; 2017 May; 96(5):580-588. PubMed ID: 28247485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of derived neutrophil-to-lymphocyte ratio, uric acid-to-creatinine ratio and Delta neutrophil index for predicting neonatal outcomes in pregnancies with preeclampsia.
    Yakiştiran B; Tanaçan A; Altinboğa O; Erol A; Şenel S; Elbayiyev S; Yücel A
    J Obstet Gynaecol; 2022 Aug; 42(6):1835-1840. PubMed ID: 35290156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia.
    Ryu A; Cho NJ; Kim YS; Lee EY
    Medicine (Baltimore); 2019 May; 98(18):e15462. PubMed ID: 31045822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.
    Ngwenya S; Jones B; Mwembe D; Nare H; Heazell AEP
    Pregnancy Hypertens; 2021 Mar; 23():18-26. PubMed ID: 33161225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria is a predictor of adverse pregnancy outcomes including preeclampsia.
    Jayaballa M; Sood S; Alahakoon I; Padmanabhan S; Cheung NW; Lee V
    Pregnancy Hypertens; 2015 Oct; 5(4):303-7. PubMed ID: 26597745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of the 24-h proteinuria in evaluating the severity of preeclampsia and predicting its adverse maternal outcomes.
    Li B; Lin L; Yang H; Zhu Y; Wei Y; Li X; Chen D; Zhao X; Cui S; Ding H; Ding G; Meng H; Wei H; Sun X; Xin H
    Hypertens Pregnancy; 2018 Aug; 37(3):118-125. PubMed ID: 30040505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study.
    Lei T; Qiu T; Liao W; Li K; Lai X; Huang H; Yuan R; Chen L
    Reprod Biol Endocrinol; 2021 May; 19(1):71. PubMed ID: 33990220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet count and platelet indices in women with preeclampsia.
    AlSheeha MA; Alaboudi RS; Alghasham MA; Iqbal J; Adam I
    Vasc Health Risk Manag; 2016; 12():477-480. PubMed ID: 27920548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia?
    Mannaerts D; Heyvaert S; De Cordt C; Macken C; Loos C; Jacquemyn Y
    J Matern Fetal Neonatal Med; 2019 May; 32(9):1412-1419. PubMed ID: 29179639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.